Organization Profile

You just read:

iCo Therapeutics Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the Treatment of Diabetic Macular Edema

News provided by

iCo Therapeutics Inc.

Jun 18, 2013, 07:00 ET